top of page


Bridging Consulting’s Insights on FDA’s Final Guidance on PCCPs Featured on Leading Platforms
Yu Zhao's article, "Decoding FDA's Final PCCP Guidance," analyzes its impact on AI-driven medical devices and combination products.
Yu Zhao
2024年12月9日讀畢需時 1 分鐘
4 次查看
0 則留言


Implementing a PCCP for Class II SaMD Products Beyond AI/ML
This white paper provides a comprehensive analysis of the PCCP,
along with practical insights into implementation priorities and approaches
Yu Zhao
2024年7月16日讀畢需時 1 分鐘
10 次查看
0 則留言


Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
Yu Zhao
2024年7月12日讀畢需時 9 分鐘
2 次查看
0 則留言


Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
Yu Zhao
2023年10月13日讀畢需時 6 分鐘
4 次查看
0 則留言


Part II: Deciphering New US Laws Around Predetermined Change Control Plan
This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).
Yu Zhao
2023年10月10日讀畢需時 11 分鐘
2 次查看
0 則留言


Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
Yu Zhao
2023年10月4日讀畢需時 5 分鐘
3 次查看
0 則留言
bottom of page